on VALNEVA (EPA:VLA)
Valneva General Meeting Approves Key Resolutions
On June 25, 2025, Valneva SE, a specialty vaccine company, announced the successful outcome of its Annual General Meeting in Lyon, France. Shareholders approved all resolutions proposed by the Board of Directors.
Significant resolutions included the approval of the 2024 financial statements, authorizations to increase the company's share capital, and the issuance of new financial instruments. Moreover, Dr. Gerd Zettlmeissl, a vaccine expert, was appointed to the Board for a three-year term, while Mr. James Sulat was reappointed for another year. Deloitte & Associés’ term as Statutory Auditor was extended for six years.
The company's management confirmed Valneva's financial guidance for the fiscal year 2025. Detailed voting results will be available on Valneva's website.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALNEVA news